No beneficial effect from addition of etoposide to daunorubicin, cytarabine, and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia: the JALSG-AML92 study. Japan Adult Leukemia Study Group.

Mitsune Tanimoto

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)97-104
Number of pages8
JournalInt J Hematol
Volume70
Issue number(2)
Publication statusPublished - 1999

Cite this